AI-driven spatial analysis of tumor-infiltrating lymphocytes predicts chemo-immunotherapy response in triple-negative

Hai Liang1, Hejie Zhu1, Liwei Wang1

  • 1Shanghai Qilu Pharmaceutical R&D Center Ltd., Shanghai, China.

Abstract

Insights

An AI framework accurately predicts triple-negative breast cancer (TNBC) treatment response by analyzing immune cell spatial organization in tumor samples. This approach enhances understanding of tumor-immune interactions for better therapeutic strategies.

Area of Science:

  • Oncology
  • Computational Biology
  • Immunology

Background:

  • Triple-negative breast cancer (TNBC) lacks targeted therapies, necessitating novel treatment strategies like neoadjuvant chemo-immunotherapy.
  • The spatial arrangement of tertiary lymphoid structures (TLS) and tumor-infiltrating lymphocytes (TILs) significantly influences treatment efficacy but is not fully understood.
  • Predicting response to chemo-immunotherapy in TNBC remains a challenge.

Purpose of the Study:

  • To develop an AI-based quantitative framework for analyzing tumor-immune spatial interactions in TNBC.
  • To create a predictive model for chemo-immunotherapy response based on spatial features.
  • To investigate the association between TLS, TILs, and treatment outcomes.

Main Methods:

  • An integrated AI pipeline was developed for automated analysis of hematoxylin-eosin (HE)-stained breast cancer samples.
  • The pipeline included TLS detection/classification, TIL quantification, and spatial relationship mapping.
  • A random forest prognostic model was constructed using multivariate statistics to identify biomarkers associated with Miller-Payne (MP) response grades.

Main Results:

  • The AI models achieved high accuracy in TLS recognition (κ=0.73) and TIL classification (0.92).
  • Analysis of 32 TNBC cases revealed that stromal lymphocyte density and proximity to tumor cells correlated with MP grades (p<0.05).
  • The spatial-feature-based prediction model demonstrated strong predictive performance with an AUC of 0.81.

Conclusions:

  • An AI-driven HE analysis pipeline effectively quantifies spatial determinants of tumor-immune interactions.
  • Lymphocyte spatial organization is a critical predictor of chemo-immunotherapy response in TNBC.
  • The validated MP-grade prediction model shows potential for clinical decision-making in TNBC management.

Related Concept Videos